Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Kay

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1985
Glucose transport protein is structurally and immunologically related to band 3 and senescent cell antigenM M Kay
Progress in Clinical and Biological Research|January 1, 1989
Red cell aging: senescent cell antigen, band 3, and band 3 mutations associated with cellular dysfunctionM M Kay
Survey and Synthesis of Pathology Research|January 1, 1985
Senescent cell antigen: a terminal differentiation antigenM M Kay
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1978
Long term subclinical effects of parainfluenza (SENDAI) infection on immune cells of aging miceM M Kay
Cellular and Molecular Biology (Noisy-Le-Grand, France)|April 29, 1998
Posttranslational changes in band 3 in aging and Alzheimer's disease: do anion and glucose transport changes reflect or foreshadow the eventual metabolic abnormalities?M M Kay
Advances in Experimental Medicine and Biology|January 1, 1980
Cells, signals, and receptors: the role of physiological autoantibodies in maintaining homeostasisM M Kay
Mechanisms of Ageing and Development|January 1, 1979
An overview of immune agingM M Kay
Monographs in Developmental Biology|January 1, 1984
Band 3, the predominant transmembrane polypeptide, undergoes proteolytic degradation as cells ageM M Kay
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 1, 1993
Generation of senescent cell antigen on old cells initiates IgG binding to a neoantigenM M Kay
Journal of Protein Chemistry|December 1, 1992
Molecular mapping of human band 3 aging antigenic sites and active amino acids using synthetic peptidesM M Kay
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1985
Glucose transport protein is structurally and immunologically related to band 3 and senescent cell antigenM M Kay
Progress in Clinical and Biological Research|January 1, 1989
Red cell aging: senescent cell antigen, band 3, and band 3 mutations associated with cellular dysfunctionM M Kay
Survey and Synthesis of Pathology Research|January 1, 1985
Senescent cell antigen: a terminal differentiation antigenM M Kay
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1978
Long term subclinical effects of parainfluenza (SENDAI) infection on immune cells of aging miceM M Kay
Cellular and Molecular Biology (Noisy-Le-Grand, France)|April 29, 1998
Posttranslational changes in band 3 in aging and Alzheimer's disease: do anion and glucose transport changes reflect or foreshadow the eventual metabolic abnormalities?M M Kay
Advances in Experimental Medicine and Biology|January 1, 1980
Cells, signals, and receptors: the role of physiological autoantibodies in maintaining homeostasisM M Kay
Mechanisms of Ageing and Development|January 1, 1979
An overview of immune agingM M Kay
Monographs in Developmental Biology|January 1, 1984
Band 3, the predominant transmembrane polypeptide, undergoes proteolytic degradation as cells ageM M Kay
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 1, 1993
Generation of senescent cell antigen on old cells initiates IgG binding to a neoantigenM M Kay
Journal of Protein Chemistry|December 1, 1992
Molecular mapping of human band 3 aging antigenic sites and active amino acids using synthetic peptidesM M Kay
Pageof 9